Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant

NCT00986804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Myelodysplastic Syndromes

Interventions

DRUG: Decitabine

Sponsor

Washington University School of Medicine